The Clinical Research of Traditional Chinese Medicine Compound Formulas

Launched by THE FOURTH AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE ·

Keywords

ClinConnect Summary

This clinical trial is studying how well and how safely a traditional Chinese medicine called Shenkangling works to treat kidney damage caused by a condition known as renal ischemia-reperfusion injury. This injury happens when blood flow to the kidneys is temporarily blocked and then restored, which can sometimes cause harm to the kidney tissue. The goal of the study is to gather solid medical evidence to help doctors decide if Shenkangling could be a helpful treatment in the future.

People who might be able to take part in this study are those within a very wide age range (though the exact numbers listed seem unusual) and of any gender. Since the trial hasn’t started recruiting yet, more specific details about who qualifies will be shared later. Participants can expect to receive the traditional medicine in a controlled way while doctors carefully monitor their health to see if the treatment helps and to check for any side effects. This study is important because it looks at a natural treatment option that could support kidney healing after injury.

Gender

ALL

Eligibility criteria